A mandate to lead research marks the creation of the National Centre for Biotechnology. It emerged in 1992 as an institute of the CSIC. The National Centre for Biotechnology addresses major challenges for today’s society. These include infectious diseases, inflammatory processes, cancer and sustainable food production. It also focuses on environmental pollution.
With over 600 workers and 70 research groups, the National Centre for Biotechnology is one of the largest centres in Spain. Experts collaborate here in molecular and cell biology. Image analysis, bioinformatics, synthetic biology, genomics, and proteomics are also key. This multidisciplinary approach enhances research quality. It enables new technologies for health, the environment, and agriculture.
The National Centre for Biotechnology’s innovation office promotes a fluid relationship with the biotechnology industry. It maintains open channels with society. This reflects the science implemented in the CNB laboratories. It connects it to the business sector and society. The CNB was created by the Government in 1985. Its inauguration occurred on July 9, 1992. The center promotes multidisciplinary research in Spain. It bridges the gap between basic research and industrial applications.
In 2013, an international jury recognized the center. It was named a Severo Ochoa Centre of Excellence in Life Sciences and Medicine. Throughout its history, the National Centre for Biotechnology has grown and evolved. It adapts to social needs. Today, it is one of Spain’s largest research centers. It has approximately 700 employees. This includes scientists, technicians, and administrative staff.
Since 2009, the 70 research groups are organized into six departments. These include Macromolecular Structure and Molecular and Cell Biology. Microbial Biotechnology, Plant Molecular Genetics, and Immunology and Oncology are included. The Department of Systems Biology is also significant.
The main mission of the National Centre for Biotechnology is to generate high-level scientific knowledge. It also develops emerging technologies. These address major societal challenges. These include infectious diseases and diseases with inflammatory components. Cancer, sustainable food production, and environmental pollution are also key. Experts in molecular and cell biology work toward these goals. Genetics, image analysis, biophysics, and bioinformatics are also vital.
The National Centre for Biotechnology is integrated within the UAM+CSIC Campus of Excellence. Its facilities train scientists and technical personnel. It advises companies and official organizations on biotechnological issues. It also disseminates its research through scientific publications.
Since its creation, the National Centre for Biotechnology has become a leading center for molecular biology in Europe. The CNB aims to acquire knowledge and develop new technologies. These focus on human and animal health, agriculture, microbiology, and the environment. It transfers scientific advances for the benefit of society. It trains future generations of researchers and technologists. Also, it informs society about the benefits of biotechnology.
The CNB conducts multidisciplinary scientific research. This focuses on structural biology and molecular biology. Virology, microbiology, and plant molecular genetics are central. Immunology, oncology, and systems biology are also key. Specific projects focus on structural biology of large macromolecules. Genomics and functional proteomics also feature. There is development of biocomputing tools and control of cell division and cancer. Other work includes mechanisms of aging and cell death. Disease study uses animal models. The CNB develops new strategies for vaccines. It researches plants and bacteria for environmental bioremediation. It generates new antibiotics. The National Centre for Biotechnology also researches coronaviruses. It develops new vaccines too.
The National Centre for Biotechnology transforms research results into applications for society. It has its technology transfer unit. This collaborates with the CSIC Vice-Presidency of Knowledge Transfer. Many research contracts are signed with companies. Numerous patents cover technologies and biological materials. These illustrate the center’s ability to apply scientific advances.
The National Centre for Biotechnology serves as a business incubator. Several biotechnology companies have emerged from it. They are driven by scientists.